The Medicines and Healthcare products Regulatory Agency (MHRA) approved marketing authorisation for Mounjaro, a new therapy, to treat type 2 diabetes in adults. This decision comes after positive results from clinical trials that showed Mounjaro remarkably decreases blood sugar levels in patients. Mounjaro represents a once-weekly injection that a